伟信医药
GREAT INNOVATION PHARMA

 To Be An  Excellent Brand of

Pharmaceutical  Intermediates Manufacturer in the world

  • 1
  • 2
  • 3
  • 4
MPP’s contribution to the global response to COVID-19
2022-3-20
source:unknown
clicks:  428        作者:未知
  • From the outset of the COVID-19 outbreak, MPP realised that equitable access to treatments would be essential in the fight against this global threat. MPP issued a statement on 5 February 2020 offering its expertise to support access to treatment through its voluntary licensing mechanism in low- and middle- income countries.

    On 31 March 2020, MPP’s Board decided to expand MPP’s mandate to include any health technology that could contribute to the global response to COVID-19 and where licensing could facilitate innovation and accelerate access.

    International Goals

    The coronavirus pandemic presents an opportunity for the world to act in solidarity and turn this crisis into an impetus to achieve the UN Sustainable Development Goals.

    MPP’s activities and contributions:

     

    [Travel report] MPP site visit to formalise discussions around the creation of the mRNA vaccine technology transfer hub in South Africa
    At the invitation of the World Health Organization and with the support of the Department of Science and Innovation of South Africa, representatives from the Medicines Patent Pool and other local and international partners of a consortium working to address the global imbalance of manufacturing capacity for COVID-19 vaccines met from 6-9 September 2021 to discuss next steps in establishing the South African mRNA vaccine technology transfer hub that will allow for greater and more diversified vaccines manufacturing capability, strengthen African regional health security and respond more equitably to the current COVID-19 pandemic and future pandemics. They also visited the Afrigen and Biovac facilities to validate conformity, compliance and alignement with the Hub concept.Read a summary of the visit
NEWS CENTER

伟信医药

GREAT INNOVATION PHARMA


Address : No.588 Zixing  Road,Zizhu National High-tech Industrial Development Zone, Minhang , Shanghai China
Zip code: 200241
Tel:8621-51143139 / 31229518  
Fax:8621-57747216 / 69517800
Website:www.gipharma.com.cn 
E-mail:sales@gipharma.com.cn

Copyright © 20011-2016,www.gipharma.com.cn ,All rights reservedCopyright © GIP Group Co., Ltd. strictly prohibit copying words without permission.